Tanzania Pharmaceuticals and Healthcare Report Q4 2017
The Tanzanian government is attempting to expand healthcare coverage to all regions of the country, recently announcing that a mandatory health insurance bill would be tabled before the end of the year. A rapidly rising low-income population of over 55 million coupled with a high disease burden will drive demand for low-cost generic medicines. We expect Tanzania's small pharmaceutical sector will experience robust growth in the coming years, although a high reliance on international aid and weak regulatory environment make it a challenging market for multinational drugmakers to operate in.
Headline Expenditure Projections
Pharmaceuticals: TZS1.00trn (USD457mn) in 2016 to an expected TZS1.11trn (USD496mn) in 2017; +10.8% growth in local currency terms and +8.4% in US dollar terms. Forecast in line with previous quarter.
Healthcare: TZS5.54trn (USD2.53bn) in 2016 to TZ6.17trn (USD2.76bn) in 2017; +11.3% growth in local currency terms, and +8.9% in US dollar terms. Forecast in line with previous quarter.